Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer

NCT02808143 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Bladder Carcinoma
Stage 0a Bladder Urothelial Carcinoma
Stage 0is Bladder Urothelial Carcinoma
Stage I Bladder Cancer

Interventions

BIOLOGICAL: BCG Solution
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
OTHER: Pharmacological Study

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]